Open access
Oct 2026
Overall survival prediction and risk stratification for advanced EGFR-mutant lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors
Nomogram including age, EGFR genotype, serum CYFRA21-1 level, and EGFR-TKI generation can predict OS and facilitate risk stratification in patients with advanced EGFR-mutated LAD receiving first-line TKIs.
Wen-Jian Tang, Jia-Wei Feng, Yuan Kang et al.
· BMC Pulmonary Medicine · 0 citations